mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.22 |
0.005 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.005 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.006 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.006 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.006 |